Q2 2024 Holdings
Filed 2024-08-12 | 25 holdings | $910.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $204.6M | 2,697,267 | 22.5% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $201.2M | 10,473,913 | 22.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $80.9M | 1,795,735 | 8.9% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $78.0M | 3,013,423 | 8.6% |
| Pharvaris N V(PHVS) | COM | N69605108 | $62.1M | 3,303,381 | 6.8% |
| Savara Inc(SVRA) | COM | 805111101 | $58.7M | 14,565,457 | 6.4% |
| Annexon Inc(ANNX) | COM | 03589W102 | $41.4M | 8,449,208 | 4.5% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $25.3M | 3,368,370 | 2.8% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $24.8M | 2,892,663 | 2.7% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $22.9M | 4,034,582 | 2.5% |
| Mersana Therapeutics Inc | COM | 59045L106 | $17.4M | 8,663,673 | 1.9% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $14.2M | 2,749,808 | 1.6% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $13.8M | 5,410,361 | 1.5% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $12.3M | 1,649,964 | 1.4% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $9.8M | 16,915,784 | 1.1% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $9.6M | 1,030,703 | 1.1% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $8.2M | 2,485,638 | 0.9% |
| Rapid Micro Biosystems Inc(RPID) | CLASS A COM | 75340L104 | $5.6M | 8,434,560 | 0.6% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $5.1M | 1,111,910 | 0.6% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $4.7M | 2,000,000 | 0.5% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $3.6M | 3,785,450 | 0.4% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $2.7M | 2,267,680 | 0.3% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $2.0M | 1,799,595 | 0.2% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $1.1M | 1,000,000 | 0.1% |
| Newamsterdam Pharma Company | *W EXP 99/99/999 | N62509117 | $872.0K | 100,000 | 0.1% |